Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ferguson plc stock logo
FERG
Ferguson
$222.68
-1.6%		$235.13
$207.64
▼
$271.64
$43.08B1.131.72 million shs278,910 shs
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
$0.00
$0.16
▼
$0.62
N/AN/A1,714 shs51,582 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ferguson plc stock logo
FERG
Ferguson
-0.83%+3.44%-11.85%+0.81%-4.70%
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ferguson plc stock logo
FERG
Ferguson
$222.68
-1.6%		$235.13
$207.64
▼
$271.64
$43.08B1.131.72 million shs278,910 shs
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
$0.00
$0.16
▼
$0.62
N/AN/A1,714 shs51,582 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ferguson plc stock logo
FERG
Ferguson
-0.83%+3.44%-11.85%+0.81%-4.70%
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ferguson plc stock logo
FERG
Ferguson
2.82
Moderate Buy$285.5728.24% Upside
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest VP, FERG, NTG, and ASY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/3/2026
Ferguson plc stock logo
FERG
Ferguson
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$295.00
9/3/2026
Ferguson plc stock logo
FERG
Ferguson
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
8/18/2026
Ferguson plc stock logo
FERG
Ferguson
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$261.00
8/11/2026
Ferguson plc stock logo
FERG
Ferguson
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$281.00 ➝ $290.00
8/11/2026
Ferguson plc stock logo
FERG
Ferguson
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$252.00 ➝ $256.00
8/11/2026
Ferguson plc stock logo
FERG
Ferguson
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$280.00 ➝ $288.00
8/11/2026
Ferguson plc stock logo
FERG
Ferguson
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$310.00 ➝ $325.00
8/11/2026
Ferguson plc stock logo
FERG
Ferguson
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$297.00 ➝ $313.00
8/11/2026
Ferguson plc stock logo
FERG
Ferguson
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$285.00 ➝ $295.00
8/11/2026
Ferguson plc stock logo
FERG
Ferguson
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$285.00 ➝ $288.00
(Data available from 9/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ferguson plc stock logo
FERG
Ferguson
$31.32B1.38$10.88 per share20.47$30.97 per share7.19
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ferguson plc stock logo
FERG
Ferguson
$1.86B$8.5126.1717.411.586.82%37.24%12.31%N/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest VP, FERG, NTG, and ASY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Ferguson plc stock logo
FERG
Ferguson
$3.23$3.39+$0.16$3.43N/A$8.75 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Ferguson plc stock logo
FERG
Ferguson
$3.561.60%+1.08%41.83%N/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/AN/A

Latest VP, FERG, NTG, and ASY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/5/2026
Ferguson plc stock logo
FERG
Ferguson
quarterly$0.891.47%8/21/20268/21/202610/7/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ferguson plc stock logo
FERG
Ferguson
0.72
1.73
0.93
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Ferguson plc stock logo
FERG
Ferguson
81.98%
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/A

Insider Ownership

CompanyInsider Ownership
Ferguson plc stock logo
FERG
Ferguson
0.15%
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Ferguson plc stock logo
FERG
Ferguson
35,000193.45 million193.16 millionN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/ANot Optionable

Recent News About These Companies

VP debate 'spin room' scene: Talking points and unscripted moments
October 22, 2024  |  usatoday.comhttps://www.usatoday.com/story/news/politics/elections/2024/10/01/vp-debate-spin-room-vibe/75450680007/
Pharma execs donated more to Democrats in campaign’s final stretch
October 21, 2024  |  statnews.comS
VitalPath hires Nicole Ramus as global sales VP
October 18, 2024  |  medicaldesignandoutsourcing.comM
Vice President Harris in ‘Excellent Health,’ Medical Report States
October 14, 2024  |  msn.comhttps://www.msn.com/en-us/health/other/vice-president-harris-in-excellent-health-medical-report-states/ar-AA1s9Apb
Vance Confident, Walz Uneven in VP Debate Heavy on Policy
October 2, 2024  |  wsj.comhttps://www.wsj.com/livecoverage/vance-walz-vice-presidential-debate-election-2024?st=5j49iZ
Read the full VP debate transcript from the Walz-Vance showdown
October 2, 2024  |  cbsnews.comhttps://www.cbsnews.com/news/full-vp-debate-transcript-walz-vance-2024/
As Investigations Swirl, Another Adams Official Resigns
September 24, 2024  |  nytimes.comhttps://www.nytimes.com/2024/09/23/nyregion/vasan-health-commissioner-resigns.html
THE CONTRERAS REPORT: Governor Newsom, veto Big Pharma’s grab for more profits
September 24, 2024  |  ivpressonline.comI
Tris Pharma Promotes Naidu to Chief Commercial Officer
September 21, 2024  |  njbmagazine.comN
No one used to care about the vice presidency. Here's how (and why) that's changed.
September 15, 2024  |  pbs.orgP
Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations
September 10, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/tonix-pharmaceuticals-announces-appointment-of-thomas-englese-as-executive-vice-president-of-commercial-operations-1033759961
KalVista Pharma Appoints Brian Piekos As New CFO
September 10, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/kalvista-pharma-appoints-brian-piekos-as-new-cfo-1033759847
For pharma, Trump versus Harris is a showdown between two industry foes
August 27, 2024  |  politifact.comP
Avive names Katerina Miras as VP of marketing
August 21, 2024  |  massdevice.comhttps://www.massdevice.com/avive-names-katerina-miras-as-vp-of-marketing/
This Bipartisan Bill Would Upend America's Pharmaceutical Industry
August 20, 2024  |  forbes.comhttps://www.forbes.com/sites/sallypipes/2024/08/19/this-bipartisan-bill-would-upend-americas-pharmaceutical-industry/
How they are reporting it: Kamala Harris' VP pick, Tim Walz
August 9, 2024  |  reuters.comhttps://www.reuters.com/world/us/how-they-are-reporting-it-kamala-harris-vp-pick-tim-walz-2024-08-07/
Kamala Harris campaign expected to announce VP running mate Tuesday morning
August 7, 2024  |  cbsnews.comhttps://www.cbsnews.com/news/harris-running-mate-tuesday-announcement/
VP Pick Walz’s Healthcare Policies Align With Harris’s Record
August 7, 2024  |  forbes.comhttps://www.forbes.com/sites/joshuacohen/2024/08/06/vp-pick-walzs-healthcare-policies-align-with-harris/
Where VP picks stand on pharmaceutical costs
August 6, 2024  |  beckershospitalreview.comB
Where Harris' VP Options Stand on Healthcare
August 2, 2024  |  msn.comhttps://www.msn.com/en-us/news/other/where-harris-vp-options-stand-on-healthcare/ar-BB1r32GA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Ferguson stock logo

Ferguson NYSE:FERG

$222.68 -3.62 (-1.60%)
As of 01:50 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Ferguson Enterprises Inc. distributes plumbing and heating products in North America. The company provides expertise, solutions, and products, including infrastructure, plumbing, appliances, fire, and fabrication, as well as heating, ventilation, and air conditioning (HVAC) to residential and non-residential customers. It also supplies specialist water and wastewater treatment products to residential, commercial, and infrastructure contractors, as well as supplies pipe, valves, and fittings solutions to industrial customers. In addition, it offers customized solutions, such as virtual design, fabrication, valve actuation, pre-assembly, kitting, installation, and project management services, as well as after-sales support that comprises warranty, credit, project-based billing, returns and maintenance, and repair and operations support. The company sells its products through a network of distribution centers, branches, counter service and specialist sales associates, showroom consultants, and e-commerce channels. Ferguson Enterprises Inc. was founded in 1953 and is headquartered in Newport News, Virginia.

Vodis Pharmaceuticals stock logo

Vodis Pharmaceuticals CNSX:VP

Vodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas